The U.S. Food and Drug Administration has issued a safety communication saying certain HeartStart automated external defibrillator devices made by Philips Medical Systems, a division of Philips ...
Amsterdam, the Netherlands and Cambridge, MA – Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced that the Center for Devices and Radiological Health (CDRH) of ...
OpenMarkets, a collaborative marketplace for capital medical equipment, has announced multiple providers have already taken advantage of its recently launched OpenMarkets MarketBuy for Philips ...
The Philips HeartStart OnSite Defibrillator is lightweight and easy to use. Providers can use the product to help save the lives of co-workers or residents, the firm notes.
Royal Philips, a global leader in health technology, announced that the Center for Devices and Radiological Health (CDRH) of the Food and Drug Administration (FDA) has approved the company’s premarket ...
Washington(CBS.MW) -- The Food and Drug Administration Thursday granted market clearance to Philips Medical Systems' HeartStart Home Defibrillator for use without a prescription. The action marks the ...
Royal Philips, a global leader in health technology, announced that the Center for Devices and Radiological Health (CDRH) of the US Food and Drug Administration (FDA) has granted premarket approval ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results